NCT02972216View on ClinicalTrials.gov

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

October 31, 2016

Conditions
Nonsmall Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Interventions
DRUG

Nolbaxol

DRUG

Taxotere

DRUG

cisplatin

All Listed Sponsors
collaborator

Taichung Veterans General Hospital

OTHER

collaborator

National Cheng-Kung University Hospital

OTHER

collaborator

Tri-Service General Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT02972216 - Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy | Biotech Hunter | Biotech Hunter